Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 5Unknown 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 5Endocrine 3Classical hematology 3Other 2Lymphoid 2Gastrointestinal 2Sarcoma 1Other hematologic neoplasm 1

Conditions

Neuroendocrine Tumors 71Pituitary Neoplasms 47Thyroid Cancer, Papillary 28Multiple Endocrine Neoplasia Type 1 21Carcinoma, Neuroendocrine 21Pheochromocytoma 18Paraganglioma 14Thyroid Neoplasms 13Carcinoid Tumor 13Neoplasm Metastasis 12Differentiated Thyroid Cancer 12Adrenocortical Carcinoma 11Neoplasms 10Thyroid Carcinoma, Anaplastic 9Pancreatic Neoplasms 8Insulinoma 8Adrenal Gland Neoplasms 8Pituitary Diseases 6Lung Neoplasms 6Hyperaldosteronism 6Gastro-enteropancreatic neuroendocrine tumor 6Acromegaly 6Stomach Neoplasms 5Prostatic Neoplasms 5Prolactinoma 5Head and Neck Neoplasms 5Carcinoma, Hepatocellular 5Breast Neoplasms 5Adrenocortical Adenoma 5Adenoma, Islet Cell 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Acquired Immunodeficiency Syndrome × Endocrine × Clear all
NCT05137210 2023-07-06

IDEaL

University of California, Los Angeles

Phase NA Unknown
569 enrolled
Endocrine

Acquired Immunodeficiency Syndrome, Multiple Endocrine Neoplasia Type 1

NCT04878601 2023-06-26

Innovative Strategies to Increase ART Initiation and Viral Suppression Among HIV-positive Men in Malawi

University of California, Los Angeles

Phase NA Unknown
470 enrolled
Endocrine

Acquired Immunodeficiency Syndrome, Multiple Endocrine Neoplasia Type 1

NCT04858243 2023-05-15

Engaging Men Through HIV Self-Testing With Differentiated Care to Improve ART Initiation and Viral Suppression Among Men in Malawi

University of California, Los Angeles

Phase NA Unknown
930 enrolled
Endocrine

Acquired Immunodeficiency Syndrome, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡